206 related articles for article (PubMed ID: 32617881)
21. Human Chorionic Gonadotropin Priming Does Not Improve Pregnancy Outcomes of PCOS-IVM Cycles.
Lin Y; Zheng X; Ma C; Li X; Zhang X; Yang P; Xu J; Zhu J
Front Endocrinol (Lausanne); 2020; 11():279. PubMed ID: 32425891
[No Abstract] [Full Text] [Related]
22. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
Gayete-Lafuente S; Turan V; Oktay KH
J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.
De Vos M; Ortega-Hrepich C; Albuz FK; Guzman L; Polyzos NP; Smitz J; Devroey P
Fertil Steril; 2011 Oct; 96(4):860-4. PubMed ID: 21868003
[TBL] [Abstract][Full Text] [Related]
24. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
25. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
[TBL] [Abstract][Full Text] [Related]
26. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles.
Fadini R; Mignini Renzini M; Guarnieri T; Dal Canto M; De Ponti E; Sutcliffe A; Shevlin M; Comi R; Coticchio G
Hum Reprod; 2012 Dec; 27(12):3601-8. PubMed ID: 23042796
[TBL] [Abstract][Full Text] [Related]
28. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Vrachnis N; Creatsa M; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2013 Oct; (10):CD006606. PubMed ID: 24101529
[TBL] [Abstract][Full Text] [Related]
29. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
Sonigo C; Bajeux J; Boubaya M; Eustache F; Sifer C; Lévy V; Grynberg M; Sermondade N
Hematol Oncol; 2020 Oct; 38(4):560-564. PubMed ID: 32065670
[TBL] [Abstract][Full Text] [Related]
30. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
31. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
[TBL] [Abstract][Full Text] [Related]
32. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
[TBL] [Abstract][Full Text] [Related]
33. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
34. [In vitro oocyte maturation for female fertility preservation].
Sonigo C; Grynberg M
Gynecol Obstet Fertil; 2014 Sep; 42(9):657-60. PubMed ID: 25153445
[TBL] [Abstract][Full Text] [Related]
35. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
36. In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.
Segers I; Mateizel I; Van Moer E; Smitz J; Tournaye H; Verheyen G; De Vos M
J Assist Reprod Genet; 2015 Aug; 32(8):1221-31. PubMed ID: 26253691
[TBL] [Abstract][Full Text] [Related]
37. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
[TBL] [Abstract][Full Text] [Related]
38. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
39. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles.
Son WY; Chung JT; Herrero B; Dean N; Demirtas E; Holzer H; Elizur S; Chian RC; Tan SL
Hum Reprod; 2008 Dec; 23(12):2680-5. PubMed ID: 18775885
[TBL] [Abstract][Full Text] [Related]
40. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
